Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
01/2003
01/23/2003US20030018195 Alpha-aminoacetic acid derivatives- alpha4beta7 receptor antagonists
01/23/2003US20030018080 N-methoxymethyl-5,5-diphenylbarbituric acid
01/23/2003US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
01/23/2003CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003CA2453451A1 Aminediols for the treatment of alzheimer's disease
01/23/2003CA2453444A1 Diaminediols for the treatment of alzheimer's disease
01/23/2003CA2453182A1 Crystalline thiazine oxazolidinones
01/23/2003CA2452513A1 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
01/22/2003EP1277743A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
01/22/2003EP1277730A1 Neovascularization inhibitors
01/22/2003EP1277729A1 Ppar (gamma) modulators
01/22/2003EP1276715A2 Method for oxidizing tertiary amines and aromatic heterocycles containing nitrogen
01/21/2003US6509494 Distillation mixture of dicyclopentenyl esters
01/21/2003US6509472 For use in enantioselective reduction of prochiral ketones to chiral secondary alcohols
01/21/2003US6509363 P38 is a mitogen-activated protein kinase; pyrrole, oxazole, thiazole, and imidazole derivatives
01/21/2003US6509354 3-arylphenyl sulfide derivative and insecticide and miticide
01/17/2003WO2002006269A1 Cyclic amino acid derivatives
01/17/2003CA2415964A1 Cyclic amino acid derivatives
01/16/2003WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma
01/16/2003WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists
01/16/2003WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents
01/16/2003WO2003004458A1 New compounds
01/16/2003WO2002046129A3 Inhibitors of histone deacetylase
01/16/2003US20030013889 Process for the preparation of taxane derivatives
01/16/2003US20030013888 Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
01/16/2003US20030013751 Viricides; enzyme inhibitors
01/16/2003US20030013747 Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents
01/16/2003US20030013730 Preventing diarrhea
01/16/2003US20030013725 Amino acid derivatives
01/16/2003US20030013100 Nucleic acid reading and analysis system
01/16/2003CA2452592A1 4-aryl quinols and analogs thereof as therapeutic agents
01/15/2003EP1274426A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
01/15/2003EP0862571B1 Herbicidal sulfonamides
01/15/2003CN1391572A Oxazolidinones having sulfoximine functionality and their use as antimicrobial agents
01/15/2003CN1391571A Heterocyclic compounds and their use as medicines
01/15/2003CN1391565A Benzophenones as inhibitors of reverse transcriptase
01/15/2003CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments
01/15/2003CN1098844C Substituted biphenyloxazolines
01/14/2003US6506908 From bicyclo(3.1.0)hexabe; decyclization; decarboxylation
01/14/2003US6506905 Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
01/14/2003US6506797 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α
01/14/2003US6506781 Prevent formation of a hydrogen bond between the agonist and tyrosine or histidine, or tryptophan involved in receptor activation; and/or b) displace the tyrosine or histidine, or tryptophan involved in receptor activation from its agonist
01/14/2003US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient
01/14/2003US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide
01/09/2003WO2003002540A1 Cyclic diamine compound having five-membered cyclic group
01/09/2003WO2003002532A1 Cyclic diamine compounds having fused-ring groups
01/09/2003WO2002020558A3 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
01/09/2003US20030009034 Transition metal mediated process
01/09/2003US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
01/09/2003US20030008906 Administering benzothiazole compound for therapy, prophylaxis of disease
01/08/2003EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia
01/08/2003EP1272537A2 Ether-amine based polymerization catalysts, compositions and processes using same
01/08/2003EP1123284B1 Method for the preparation of citalopram
01/08/2003CN1390211A Benzoic ester comprising ethoxyl acyl piperazine substituted oxazolidone compound
01/08/2003CN1390210A Process for preparing oxazolines from tetrahydrofurans
01/08/2003CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties
01/08/2003CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties
01/08/2003CN1390122A Tissue factor antagonists and methods of use thereof
01/08/2003CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect
01/08/2003CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
01/07/2003US6504046 Process for the preparation of amides
01/07/2003US6503979 Production of diapers, tampons, sanitary towels and other hygiene articles
01/07/2003US6503935 Imidazoles and related compounds as α1A agonists
01/07/2003CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease
01/03/2003WO2003000669A1 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides
01/03/2003WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents
01/03/2003WO2002083656A3 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
01/03/2003WO2002064577A3 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
01/02/2003US20030004212 Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists
01/02/2003US20030004193 Immunomodulators; antiinflammatory agents
01/02/2003US20030004160 Method for the preparation of oxazolidinones
01/02/2003EP1268473A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors
01/02/2003EP1268461A1 Process for the preparation of citalopram
01/02/2003EP1268096A1 Extrusion die
01/02/2003EP1267867A1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists
01/02/2003EP0821719B1 Liquid crystal compounds having a chiral fluorinated terminal portion
01/02/2003EP0751939B9 Naphthylamides as central nervous system agents
01/01/2003CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen
01/01/2003CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack
01/01/2003CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack
01/01/2003CN1097583C Process for preparing intermediates of florfenicol
12/2002
12/31/2002US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors
12/26/2002US20020198245 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002US20020198244 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/25/2002CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists
12/25/2002CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/24/2002US6498276 Reacting amido acetic acid derivative with thionyl chloride to form oxazole compound which is reacted with halobenzoly compound
12/24/2002US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/24/2002US6498256 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds.
12/24/2002US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002US6498179 Such as 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl)-2-(2-methyl-1 -imidazolyl)oxazole; insulin secertion promoting and blood sugar depressing effect; diabetes; low toxicity
12/24/2002US6498178 Inhibitors of IMPDH enzyme
12/24/2002US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome
12/24/2002US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/19/2002WO2002100977A1 Organic electroluminescence device and luminance material
12/19/2002WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100842A1 Sulfonyloxazolamines and their use as 5-ht6 ligands